Government’s RICO Case Against NECC is Unprecedented
This article was originally published in The Gold Sheet
A 131-count indictment unsealed last month that includes murder and racketeering allegations against New England Compounding Center pharmacists for violations of the FD&C Act is unprecedented and signals that the federal government is using more aggressive legal tools in prosecuting individuals whose products harm or kill consumers.
You may also be interested in...
While COVID-19 continues to wreak havoc on FDA's ability to perform onsite preapproval inspections, new guidance offers some clarity, but the news isn't great for ANDA holders.
The WHO proposes to revise 2011 guidance on technology transfers to ease the hand-off of COVID-19 drugs and vaccines from research and development facilities to commercial sites.